NCT01979536 2024-04-30Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell LymphomaNational Cancer Institute (NCI)Phase 2 Completed137 enrolled 13 charts